News

DeHeng Advised West Lake OMI on Completing Seed Financing

of Tens of Millions of Yuan

2021-03-05


Recently, West Lake OMI (Hangzhou) Biotechnology Co., Ltd. announced the completion of tens of millions of yuan of seed round funding, with CD Capital and Gaorong Capital as joint lead investors, followed by GL Ventures.


Guo Tiannan, the founder of West Lake OMI, is a veteran researcher in proteomics, and boasts many original achievements in the development and application of proteomics technologies. Guo's lab and partners were the first to complete the analysis of serum proteome and metabolism in COVID-19 patients with mild and severe symptoms, find a series of important biomarkers with characteristics of severe patients, map the world's first panoramic view of the regulation of multiple organ protein molecules in patients who died of COVID-19. Their research findings were published in the journal Cell, and are expected to provide guidance for predicting the development of from mild to severe cases.


As legal counsel to West Lake OMI, the DeHeng team, with primary support from partner Ji Shujuan, lawyers Yin Tang and Feng Yaqun, participated in the whole process of the transaction structure design, transaction document review, negotiations, and project delivery on behalf of the client. They worked closely with each other and completed the work in a professional and efficient manner, winning high recognition of the client.

Search

QR Code

Scan QR Code
Share With My Friends